一个喷雾干燥的复制品疫苗平台,用于疫情应对
Wynton D McClary1, John Z Chen1, Hui Wang2
1Access to Advanced Health Institute, Seattle, WA 98102, USA.
International journal of pharmaceutics
|May 28, 2025
概括
这项研究证明了对H5N1禽流感的热稳定纳米结构脂质载体 (NLC) 疫苗的喷雾干燥. 这种方法提高了疫苗的稳定性和为全球快速应对疫情做好准备.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 纳米技术纳米技术
- 生物技术是生物技术.
背景情况:
- 由于COVID-19和H5N1的威胁,需要热稳定的疫苗来快速应对大流行.
- 之前开发的纳米结构脂质载体 (NLC) 复制体疫苗平台提供了快速,可扩展的制造.
- 喷雾干燥为疫苗干燥提供了低成本,可扩展的冷化替代方案.
研究的目的:
- 为了证明喷雾干燥H5N1禽流感复制NLC疫苗的可行性.
- 提高疫苗的长期热稳定性和免疫性.
- 探索通过鼻腔或肺部输送干粉疫苗的潜力.
主要方法:
- 对形成玻璃的二糖化辅助剂进行选,以检测喷雾干燥的兼容性.
- 对复制品-NLC疫苗复合物的喷雾干燥条件的优化.
- 对喷雾干燥疫苗的化学稳定性,免疫性和空气动力学颗粒大小的评估.
主要成果:
- 成功喷雾干燥H5N1复制体-NLC疫苗,在40°C下至少一个月产生化学稳定的粉末.
- 在4°C的温度下至少维持了三个月的疫苗免疫性,当它被制并给小鼠.
- 对潜在的干粉吸入输送的空气动力学颗粒大小的证明控制.
结论:
- 喷雾干燥是一种生产热稳定,免疫原复制NLC疫苗的可行方法.
- 这项技术通过提高疫苗稳定性和可扩展的制造提高了疫情防控能力.
- 干粉输送的潜力为疫苗的管理提供了新的途径.
相关概念视频
01:51Vaccinations
Overview
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...